How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2010, Issue , 2010, Pages 314-321

  Blum, William ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOLOGIC AGENT;

CLINICAL TRIAL (TOPIC); DRUG ADMINISTRATION; HUMAN; MYELODYSPLASTIC SYNDROME; PRACTICE GUIDELINE; REVIEW; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; GUIDELINES AS TOPIC; HEMATOLOGIC AGENTS; HUMANS; MYELODYSPLASTIC SYNDROMES; TREATMENT OUTCOME;

EID: 79955040190     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2010.1.314     Document Type: Review

References (0)